Back to Results

NRG-GU002, PHASE II-III TRIAL OF ADJUVANT RADIOTHERAPY AND ANDROGEN DEPRIVATION FOLLOWING RADICAL PROSTATECTOMY WITH OR WITHOUT ADJUVANT DOCETAXEL

Primary Objective

A comparison of adjuvant radiotherapy + androgen therapy after a radical prostatectomy with and without Docetaxel.

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Phase

II/III - A combination of phases: (2) Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied. and (3) Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.

Type of Study

Treatment

Locations

Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Pikes Peak Regional Hospital
Poudre Valley Hospital
University of Colorado Hospital

Principal Investigator
Elizabeth Kessler,  MD

Elizabeth Kessler, MD

Study ID

Protocol Number: 17-0266

ClinicalTrials.gov: NCT03070886

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers